External Oblique Intercostal Block Versus Transversus Abdominis Plane Block in Pediatric Laparoscopic Splenectomy
Optimizing Regional Analgesia in Pediatric Laparoscopic Splenectomy: External Oblique Intercostal Block Versus Transversus Abdominis Plane Block: Randomized Controlled Study
1 other identifier
interventional
60
1 country
1
Brief Summary
The aim of study is to compare the efficacy of the External Oblique Intercostal plane block with the Transversus Abdominis Plane block in acute postoperative pain control in pediatric patients undergoing laparoscopic Splenectomy.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Jan 2026
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
January 2, 2026
CompletedFirst Posted
Study publicly available on registry
January 13, 2026
CompletedStudy Start
First participant enrolled
January 13, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 30, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
July 30, 2026
May 22, 2026
January 1, 2026
7 months
January 2, 2026
May 19, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Numerical rating scale score
Numerical rating scale score
Numerical rating scale score will be assessed postoperatively 10, 30 and 60 minutes then 2 , 4 , 6 , 12 , 24 hours postoperatively
Secondary Outcomes (1)
Intraoperative Heart rate values
every 15 minutes until end of surgery
Study Arms (2)
EOI group (Group E)
EXPERIMENTAL30 patients will receive ultrasound-guided left EOI block
TAP group (Group T)
EXPERIMENTAL30 patients will receive ultrasound-guided left TAP block
Interventions
Eligibility Criteria
You may qualify if:
- Children of both gender,
- aged 8 to 16 years with American Society of Anesthesiologists Physical Status I to III,
- who were scheduled for laparoscopic Splenectomy surgery.
You may not qualify if:
- Parents declined to participate in the trial.
- Physical or developmental delay.
- Pre-existing renal or cardiovascular disease, bone disease, or gastrointestinal disorders.
- Infection at proposed injection sites.
- Prior major abdominal surgery
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Tanta Universitylead
Study Sites (1)
Tanta University
Tanta, Egypt
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, CARE PROVIDER
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Lecturer
Study Record Dates
First Submitted
January 2, 2026
First Posted
January 13, 2026
Study Start
January 13, 2026
Primary Completion (Estimated)
July 30, 2026
Study Completion (Estimated)
July 30, 2026
Last Updated
May 22, 2026
Record last verified: 2026-01
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL, SAP, ICF
All data will be provided if it was needed